Alveolar lining fluid S-nitrosoglutathione may contribute as a source of airway gaseous nitric oxide

T. T. Vovan, Steven George, S. J. Kwon, A. Aledia, J. H. Roum

Research output: Contribution to journalArticle

Abstract

Nitric oxide (NO) has normal physiologic functions in the lung serving both as a bronchodilator and vasodilatator. Glutathione (GSH), found in abundance in the alveolar epithelial lining fluid (ELF), has been studied as an extracellular antioxidant and may also react with NO in the ELF to form a S-nitrosothiol, S-Nitrosoglutathione (GSNO). In vitro, GSNO also demonstrates bronchodilatory and vasodilatory activities. We hypothesized that GSNO in ELF may serve as a source of exhaled NO in the alveolar air by the breakdown to GSH and NO followed by the partition of NO between liquid to gas phase. To test this, we measured the presence of NO in the head space gas from various solution containing known concentration of GSNO or Sodium Nitrate (NaNO3). These solutions (either with Phosphate Buffered Saline (PBS, pH7.4) or cell culture media [containing HEPES Buffer, DME-S12, Non-essential amino acid, Bovine Serum Albumin, and L-glutamine]) were placed in sealed glass chambers (10 mL solution, 125 mL chambers). NO gas was measured utilizing a chemilucent reaction detected by a NO analyzer (Seivers 280). At one hour, NO gas (2.5 ±0.1ppm, mean± SEM) was present in the head space of a 10mL solution containing GSNO [100μM] in PBS. We found that the presence of NO gas was substantially higher from PBS solution containing GSNO than PBS solution containing equimolar concentration of NaNO3 (p <0.002, at 1 hour). Gas phase partial pressure of NO increased both as a function of the concentration of GSNO and time (p<0.00001, p < 0.016 respectively). The release of NO from GSNO in cell culture media was significantly increased in comparison to GSNO in PBS alone (p < 0.002). We conclude that GSNO in solution is able to release nitric oxide. In addition, this release may be further enhanced in biological fluids. Thus, in ELF, the presence of GSNO may serve as an important source of airway gaseous nitric oxide in both the normal lung function and may have a role for therapeutic intervention.

Original languageEnglish (US)
JournalJournal of Investigative Medicine
Volume47
Issue number2
StatePublished - Jan 1 1999
Externally publishedYes

Fingerprint

S-Nitrosoglutathione
Linings
Nitric Oxide
Fluids
Gases
Cell culture
Culture Media
Cell Culture Techniques
Head
S-Nitrosothiols
HEPES
Lung
Partial Pressure
Bronchodilator Agents
Bovine Serum Albumin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Alveolar lining fluid S-nitrosoglutathione may contribute as a source of airway gaseous nitric oxide. / Vovan, T. T.; George, Steven; Kwon, S. J.; Aledia, A.; Roum, J. H.

In: Journal of Investigative Medicine, Vol. 47, No. 2, 01.01.1999.

Research output: Contribution to journalArticle

@article{e80b08eb8786478195ef2ac0dcb449c9,
title = "Alveolar lining fluid S-nitrosoglutathione may contribute as a source of airway gaseous nitric oxide",
abstract = "Nitric oxide (NO) has normal physiologic functions in the lung serving both as a bronchodilator and vasodilatator. Glutathione (GSH), found in abundance in the alveolar epithelial lining fluid (ELF), has been studied as an extracellular antioxidant and may also react with NO in the ELF to form a S-nitrosothiol, S-Nitrosoglutathione (GSNO). In vitro, GSNO also demonstrates bronchodilatory and vasodilatory activities. We hypothesized that GSNO in ELF may serve as a source of exhaled NO in the alveolar air by the breakdown to GSH and NO followed by the partition of NO between liquid to gas phase. To test this, we measured the presence of NO in the head space gas from various solution containing known concentration of GSNO or Sodium Nitrate (NaNO3). These solutions (either with Phosphate Buffered Saline (PBS, pH7.4) or cell culture media [containing HEPES Buffer, DME-S12, Non-essential amino acid, Bovine Serum Albumin, and L-glutamine]) were placed in sealed glass chambers (10 mL solution, 125 mL chambers). NO gas was measured utilizing a chemilucent reaction detected by a NO analyzer (Seivers 280). At one hour, NO gas (2.5 ±0.1ppm, mean± SEM) was present in the head space of a 10mL solution containing GSNO [100μM] in PBS. We found that the presence of NO gas was substantially higher from PBS solution containing GSNO than PBS solution containing equimolar concentration of NaNO3 (p <0.002, at 1 hour). Gas phase partial pressure of NO increased both as a function of the concentration of GSNO and time (p<0.00001, p < 0.016 respectively). The release of NO from GSNO in cell culture media was significantly increased in comparison to GSNO in PBS alone (p < 0.002). We conclude that GSNO in solution is able to release nitric oxide. In addition, this release may be further enhanced in biological fluids. Thus, in ELF, the presence of GSNO may serve as an important source of airway gaseous nitric oxide in both the normal lung function and may have a role for therapeutic intervention.",
author = "Vovan, {T. T.} and Steven George and Kwon, {S. J.} and A. Aledia and Roum, {J. H.}",
year = "1999",
month = "1",
day = "1",
language = "English (US)",
volume = "47",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Alveolar lining fluid S-nitrosoglutathione may contribute as a source of airway gaseous nitric oxide

AU - Vovan, T. T.

AU - George, Steven

AU - Kwon, S. J.

AU - Aledia, A.

AU - Roum, J. H.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Nitric oxide (NO) has normal physiologic functions in the lung serving both as a bronchodilator and vasodilatator. Glutathione (GSH), found in abundance in the alveolar epithelial lining fluid (ELF), has been studied as an extracellular antioxidant and may also react with NO in the ELF to form a S-nitrosothiol, S-Nitrosoglutathione (GSNO). In vitro, GSNO also demonstrates bronchodilatory and vasodilatory activities. We hypothesized that GSNO in ELF may serve as a source of exhaled NO in the alveolar air by the breakdown to GSH and NO followed by the partition of NO between liquid to gas phase. To test this, we measured the presence of NO in the head space gas from various solution containing known concentration of GSNO or Sodium Nitrate (NaNO3). These solutions (either with Phosphate Buffered Saline (PBS, pH7.4) or cell culture media [containing HEPES Buffer, DME-S12, Non-essential amino acid, Bovine Serum Albumin, and L-glutamine]) were placed in sealed glass chambers (10 mL solution, 125 mL chambers). NO gas was measured utilizing a chemilucent reaction detected by a NO analyzer (Seivers 280). At one hour, NO gas (2.5 ±0.1ppm, mean± SEM) was present in the head space of a 10mL solution containing GSNO [100μM] in PBS. We found that the presence of NO gas was substantially higher from PBS solution containing GSNO than PBS solution containing equimolar concentration of NaNO3 (p <0.002, at 1 hour). Gas phase partial pressure of NO increased both as a function of the concentration of GSNO and time (p<0.00001, p < 0.016 respectively). The release of NO from GSNO in cell culture media was significantly increased in comparison to GSNO in PBS alone (p < 0.002). We conclude that GSNO in solution is able to release nitric oxide. In addition, this release may be further enhanced in biological fluids. Thus, in ELF, the presence of GSNO may serve as an important source of airway gaseous nitric oxide in both the normal lung function and may have a role for therapeutic intervention.

AB - Nitric oxide (NO) has normal physiologic functions in the lung serving both as a bronchodilator and vasodilatator. Glutathione (GSH), found in abundance in the alveolar epithelial lining fluid (ELF), has been studied as an extracellular antioxidant and may also react with NO in the ELF to form a S-nitrosothiol, S-Nitrosoglutathione (GSNO). In vitro, GSNO also demonstrates bronchodilatory and vasodilatory activities. We hypothesized that GSNO in ELF may serve as a source of exhaled NO in the alveolar air by the breakdown to GSH and NO followed by the partition of NO between liquid to gas phase. To test this, we measured the presence of NO in the head space gas from various solution containing known concentration of GSNO or Sodium Nitrate (NaNO3). These solutions (either with Phosphate Buffered Saline (PBS, pH7.4) or cell culture media [containing HEPES Buffer, DME-S12, Non-essential amino acid, Bovine Serum Albumin, and L-glutamine]) were placed in sealed glass chambers (10 mL solution, 125 mL chambers). NO gas was measured utilizing a chemilucent reaction detected by a NO analyzer (Seivers 280). At one hour, NO gas (2.5 ±0.1ppm, mean± SEM) was present in the head space of a 10mL solution containing GSNO [100μM] in PBS. We found that the presence of NO gas was substantially higher from PBS solution containing GSNO than PBS solution containing equimolar concentration of NaNO3 (p <0.002, at 1 hour). Gas phase partial pressure of NO increased both as a function of the concentration of GSNO and time (p<0.00001, p < 0.016 respectively). The release of NO from GSNO in cell culture media was significantly increased in comparison to GSNO in PBS alone (p < 0.002). We conclude that GSNO in solution is able to release nitric oxide. In addition, this release may be further enhanced in biological fluids. Thus, in ELF, the presence of GSNO may serve as an important source of airway gaseous nitric oxide in both the normal lung function and may have a role for therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=33750100721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750100721&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750100721

VL - 47

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 2

ER -